Avalglucosidase alfa French post-trial access for participants with Pompe disease (PTA Avalglucosidase)

Trial Identifier: PTA17333
Sponsor: Genzyme, a Sanofi Company
Start Date: July 2022
Primary Completion Date: September 2026
Study Completion Date: September 2026
Condition: Pompe Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France BREST, France, 29609
France Lille, France, 59037
France MARSEILLE, France, 13385
France Nantes, France, 44093
France NICE, France, 06200
France Paris, France, 75015
France PARIS, France, 75013
France Tours, France, 37044
FRANCE Bordeaux, FRANCE, 33000
FRANCE Clermont-Ferrand, FRANCE, 63000
FRANCE Lyon, FRANCE, 69003